LUFYLLIN Drug Patent Profile
✉ Email this page to a colleague
When do Lufyllin patents expire, and what generic alternatives are available?
Lufyllin is a drug marketed by Norvium Bioscience and is included in one NDA.
The generic ingredient in LUFYLLIN is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUFYLLIN?
- What are the global sales for LUFYLLIN?
- What is Average Wholesale Price for LUFYLLIN?
Summary for LUFYLLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 3,310 |
| DailyMed Link: | LUFYLLIN at DailyMed |
US Patents and Regulatory Information for LUFYLLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
